Aviva’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.64M Sell
46,190
-2,959
-6% -$105K ﹤0.01% 643
2025
Q1
$1.67M Buy
49,149
+849
+2% +$28.8K ﹤0.01% 590
2024
Q4
$1.57M Buy
48,300
+1,700
+4% +$55.3K ﹤0.01% 607
2024
Q3
$2.27M Sell
46,600
-400
-0.9% -$19.5K 0.01% 537
2024
Q2
$2.08M Hold
47,000
0.01% 576
2024
Q1
$2.64M Buy
47,000
+3,000
+7% +$168K 0.01% 564
2023
Q4
$2.65M Buy
44,000
+8,100
+23% +$487K 0.01% 568
2023
Q3
$2.41M Hold
35,900
0.01% 596
2023
Q2
$2.48M Buy
35,900
+2,100
+6% +$145K 0.01% 596
2023
Q1
$1.63M Buy
33,800
+5,000
+17% +$241K 0.01% 697
2022
Q4
$1.44M Buy
28,800
+2,300
+9% +$115K 0.01% 745
2022
Q3
$1.08M Buy
26,500
+2,900
+12% +$118K 0.01% 903
2022
Q2
$1.3M Buy
23,600
+3,400
+17% +$187K 0.01% 933
2022
Q1
$734K Buy
20,200
+3,600
+22% +$131K ﹤0.01% 998
2021
Q4
$774K Buy
+16,600
New +$774K ﹤0.01% 956